Based on the analysis result: 44.0% acute myeloid leukemia (AML), 16.8% B - acute lymphoblastic leukemia (B-ALL), 6.4% of T - acute lymphoblastic leukemia (T-ALL), 2.4% of plasmocyte, 0.8% of hematogones, 8.0% of single cell B-lymphocyte proliferation, 21.6% of others.